Blog Posts

Stay up to date with the latest biotech data analytic news

Blog Post

Qualia Bio Announces Acquisition by BluePath Solutions

BluePath Solutions, a leading health economics and value communication consulting firm, has acquired Qualia Bio.

Blog Post

Qualia Bio Announces Acquisition by BluePath Solutions

BluePath Solutions, a leading health economics and value communication consulting firm, has acquired Qualia Bio.

Blog Post

Top 20 Medicare Part B Drug Price Trends

This article will focus on the role of Part B drug prices and how they have changed over time.

Blog Post

CMS issued final guidance on the Identification of Selected Drugs for Initial Price Applicability Year 2026

The Department of Health and Human Services Centers for Medicare and Medicaid Services (CMS) recently released initial g...

Blog Post

Physician's Offices Can Now Officially Get Reimbursed for CAR T by Medicare FFS

A Change Request to the CAR T NCD Clarifies Billing Requirements for Outpatient Physician's Offices Administering CAR T ...

Blog Post

Double Check! Medicare Advantage Denials Aren't Always Right, Says the OIG

OIG case file reviews found that Medicare Advantage Organizations delayed or denied some Medicare Advantage beneficiarie...

Blog Post

Medicare Part B Discarded Drug Refund Legislation

In today’s post, we will review new legislation which gives CMS the authority to require refunds from manufacturers of M...

Blog Post

CAR-T Kickback Exemptions: Different Rules for Curative Treatments?

OIG determined Novartis’ CAR-T patient support program was not a kickback, paving the way for other CAR-T manufacturers ...

Search

Showing 10 of 52